276 related articles for article (PubMed ID: 29359980)
1. Genome-wide sequencing and quantification of circulating microRNAs for dogs with congestive heart failure secondary to myxomatous mitral valve degeneration.
Jung S; Bohan A
Am J Vet Res; 2018 Feb; 79(2):163-169. PubMed ID: 29359980
[TBL] [Abstract][Full Text] [Related]
2. Expression Profiling of Circulating MicroRNAs in Canine Myxomatous Mitral Valve Disease.
Li Q; Freeman LM; Rush JE; Laflamme DP
Int J Mol Sci; 2015 Jun; 16(6):14098-108. PubMed ID: 26101868
[TBL] [Abstract][Full Text] [Related]
3. Increased NT-proANP predicts risk of congestive heart failure in Cavalier King Charles spaniels with mitral regurgitation caused by myxomatous valve disease.
Eriksson AS; Häggström J; Pedersen HD; Hansson K; Järvinen AK; Haukka J; Kvart C
J Vet Cardiol; 2014 Sep; 16(3):141-54. PubMed ID: 25130405
[TBL] [Abstract][Full Text] [Related]
4. Circulating exosome microRNA associated with heart failure secondary to myxomatous mitral valve disease in a naturally occurring canine model.
Yang VK; Loughran KA; Meola DM; Juhr CM; Thane KE; Davis AM; Hoffman AM
J Extracell Vesicles; 2017; 6(1):1350088. PubMed ID: 28804599
[TBL] [Abstract][Full Text] [Related]
5. Plasma and serum serotonin concentrations and surface-bound platelet serotonin expression in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
Cremer SE; Kristensen AT; Reimann MJ; Eriksen NB; Petersen SF; Marschner CB; Tarnow I; Oyama MA; Olsen LH
Am J Vet Res; 2015 Jun; 76(6):520-31. PubMed ID: 26000599
[TBL] [Abstract][Full Text] [Related]
6. Atrial Fibrillation as a Prognostic Indicator in Medium to Large-Sized Dogs with Myxomatous Mitral Valvular Degeneration and Congestive Heart Failure.
Jung SW; Sun W; Griffiths LG; Kittleson MD
J Vet Intern Med; 2016; 30(1):51-7. PubMed ID: 26681398
[TBL] [Abstract][Full Text] [Related]
7. Increased serum C-reactive protein concentrations in dogs with congestive heart failure due to myxomatous mitral valve disease.
Reimann MJ; Ljungvall I; Hillström A; Møller JE; Hagman R; Falk T; Höglund K; Häggström J; Olsen LH
Vet J; 2016 Mar; 209():113-8. PubMed ID: 26831162
[TBL] [Abstract][Full Text] [Related]
8. Echocardiographic parameters for the assessment of congestive heart failure in dogs with myxomatous mitral valve disease and moderate to severe mitral regurgitation.
Morgan KRS; Monteith G; Raheb S; Colpitts M; Fonfara S
Vet J; 2020 Sep; 263():105518. PubMed ID: 32928487
[TBL] [Abstract][Full Text] [Related]
9. Cardiac troponin-I concentration, myocardial arteriosclerosis, and fibrosis in dogs with congestive heart failure because of myxomatous mitral valve disease.
Falk T; Ljungvall I; Zois NE; Höglund K; Olsen LH; Pedersen HD; Häggström J
J Vet Intern Med; 2013; 27(3):500-6. PubMed ID: 23551840
[TBL] [Abstract][Full Text] [Related]
10. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.
Rasmussen CE; Falk T; Zois NE; Moesgaard SG; Häggström J; Pedersen HD; Ablad B; Nilsen HY; Olsen LH
J Vet Intern Med; 2012; 26(1):76-84. PubMed ID: 22151356
[TBL] [Abstract][Full Text] [Related]
11. Markers of Oxidative Stress in Dogs with Myxomatous Mitral Valve Disease are Influenced by Sex, Neuter Status, and Serum Cholesterol Concentration.
Reimann MJ; Häggström J; Møller JE; Lykkesfeldt J; Falk T; Olsen LH
J Vet Intern Med; 2017 Mar; 31(2):295-302. PubMed ID: 28132441
[TBL] [Abstract][Full Text] [Related]
12. Effect of pimobendan on the incidence of arrhythmias in small breed dogs with myxomatous mitral valve degeneration.
Lake-Bakaar GA; Singh MK; Kass PH; Griffiths LG
J Vet Cardiol; 2015 Jun; 17(2):120-8. PubMed ID: 26007710
[TBL] [Abstract][Full Text] [Related]
13. Expression Profile of Circulating MicroRNAs in Dogs With Cardiac Hypertrophy: A Pilot Study.
Ro WB; Kang MH; Song DW; Lee SH; Park HM
Front Vet Sci; 2021; 8():652224. PubMed ID: 33898546
[TBL] [Abstract][Full Text] [Related]
14. Serum Concentrations of Leptin and Adiponectin in Dogs with Myxomatous Mitral Valve Disease.
Kim HS; Kang JH; Jeung EB; Yang MP
J Vet Intern Med; 2016 Sep; 30(5):1589-1600. PubMed ID: 27573621
[TBL] [Abstract][Full Text] [Related]
15. Plasma and platelet serotonin concentrations in healthy dogs and dogs with myxomatous mitral valve disease.
Mangklabruks T; Surachetpong SD
J Vet Cardiol; 2014 Sep; 16(3):155-62. PubMed ID: 25127665
[TBL] [Abstract][Full Text] [Related]
16. Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity.
Valente C; Guglielmini C; Domenech O; Contiero B; Zini E; Poser H
PLoS One; 2020; 15(9):e0238440. PubMed ID: 32870923
[TBL] [Abstract][Full Text] [Related]
17. Partial external mitral annuloplasty in dogs with myxomatous mitral valve degeneration and congestive heart failure: outcome in 9 cases.
de Andrade JN; Christopher Orton E; Boon J; Nishimori CT; Olivaes C; Camacho AA
J Vet Cardiol; 2011 Sep; 13(3):197-201. PubMed ID: 21824833
[TBL] [Abstract][Full Text] [Related]
18. Mitral valve transcriptome analysis in thirty-four age-matched Cavalier King Charles Spaniels with or without congestive heart failure caused by myxomatous mitral valve disease.
Reimann MJ; Cremer S; Christiansen L; Ibragimov E; Gao F; Cirera S; Fredholm M; Olsen LH; Karlskov-Mortensen P
Mamm Genome; 2024 Mar; 35(1):77-89. PubMed ID: 37938355
[TBL] [Abstract][Full Text] [Related]
19. Tissue Doppler and strain imaging in dogs with myxomatous mitral valve disease in different stages of congestive heart failure.
Tidholm A; Ljungvall I; Höglund K; Westling AB; Häggström J
J Vet Intern Med; 2009; 23(6):1197-207. PubMed ID: 19909428
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil-to-lymphocyte ratio is increased in dogs with acute congestive heart failure secondary to myxomatous mitral valve disease compared to both dogs with heart murmurs and healthy controls.
DeProspero DJ; Hess RS; Silverstein DC
J Am Vet Med Assoc; 2023 Nov; 261(11):1-8. PubMed ID: 37406992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
